Komori
Kidswell Bio (4584) · PolicyRestated

No-dividend policy prioritizing retained earnings and reinvestment in research and development

First written in FY2016. 4 of 5 entries say "Restated". Latest entry: FY2020.

5entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20202016: 120162017: 120172018: 120182019: 120192020: 12020
Same theme, other companies
No-dividend policy prioritizing research activities and strengthening the financial positionA theme 7 companies write about · 3 as a headwind · 2 as a tailwind

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2020RestatedAnnual report

    「For the time being, we aim to achieve profitability early and will prioritize strengthening our financial position through retained earnings and reinvesting in research and development activities.」

    The company has reaffirmed its policy of prioritizing strengthening its financial position and reinvesting in research and development, on the assumption that no dividends will be paid.
  2. FY2019RestatedAnnual report

    「For the time being, we aim to achieve profitability early and will prioritize strengthening our financial position through retained earnings and reinvesting in research and development activities.」

    The company has reaffirmed its policy of prioritizing strengthening its financial position and reinvesting in research and development, on the assumption that no dividends will be paid.
  3. FY2018RestatedAnnual report

    「For the time being, we aim to achieve profitability early and will prioritize strengthening our financial position through retained earnings and reinvesting in research and development activities.」

    The company continues to prioritize strengthening its financial position and reinvesting in research and development, on the assumption that no dividends will be paid for the time being.
  4. FY2017RestatedAnnual report

    「For the time being, we aim to achieve profitability early and will prioritize strengthening our financial position through retained earnings and reinvesting in research and development activities.」

    The company continues to prioritize strengthening its financial position and reinvesting in research and development, on the assumption that no dividends will be paid for the time being.
  5. FY2016First statedAnnual report

    「For the time being, we aim to achieve profitability early and will prioritize strengthening our financial position through retained earnings and reinvesting in research and development activities.」

    The company has paid no dividends since its founding and is currently prioritizing strengthening its financial position and reinvesting in research and development, while considering the introduction of dividends in the future.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kidswell Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
No-dividend policy prioritizing retained earnings and reinvestment in research and development | Kidswell Bio Corporation (4584) | Komori